Edgewise Therapeutics is a biopharmaceutical company that develops and commercializes small molecule therapeutics to treat musculoskeletal diseases.
$200M
Apr 02, 2025
-
Curevo is a Washington-based biotechnology company that researches and develops vaccines for the treatment of infectious diseases.
$110M
Mar 05, 2025
-
$90M
Feb 13, 2025
-
$140M
Dec 18, 2024
-
Angitia is a China-based clinical-stage biotechnology company that researches and develops novel therapeutics for the treatment of musculoskeletal diseases.
$120M
Dec 10, 2024
-
Frequently Asked Questions about Janus Henderson
What is Janus Henderson investing in?
Janus Henderson has invested in 127 companies including Edgewise Therapeutics, Curevo and Bambusa Therapeutics
What company did Janus Henderson invest in?
Janus Henderson invested in a total 127 companies including Edgewise Therapeutics, Curevo and Bambusa Therapeutics
What are the top 5 investments by Janus Henderson?
The top companies in which Janus Henderson invested are Edgewise Therapeutics, Curevo, Bambusa Therapeutics, Ottimo Pharma and Angitia
